Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising incidence of chronic diseases
3.2.1.2 Advancements in cell-based therapies
3.2.1.3 Increasing biomedical research activities
3.2.1.4 Growing focus on personalized medicine
3.2.2 Industry pitfalls & challenges
3.2.2.1 High costs of technology development and implementation
3.2.2.2 Limited standardization of techniques
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Detergent
5.3 Organic solvent
5.4 Pore-forming agents
5.5 Enzymatic permeabilization
5.6 Other product types
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Drug delivery
6.3 Gene transfection
6.4 Cellular imaging
6.5 Other applications
Chapter 7 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Contract research organizations
7.3 Pharmaceutical and biotechnology companies
7.4 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Agilent Technologies, Inc.
9.2 Boster Biological Technology
9.3 Cell Signaling Technology, Inc.
9.4 Cyanagen
9.5 Danaher Corporation
9.6 F. Hoffmann-La Roche Ltd.
9.7 Illumina, Inc.
9.8 International Stem Cell Corporation
9.9 IQ Products
9.10 PerkinElmer, Inc.
9.11 Promega Corporation
9.12 Qiagen N.V.
9.13 Sartorius AG
9.14 Standard Biotools Inc.
9.15 Thermo Fisher Scientific, Inc.
